Aspire Biopharma Holdings Inc. Ordinary Shares - Class A ASBP 深 沪
已收盘 10-31 16:00:00 美东时间
0.3825
+0.006
+1.62%
华盛通- 最 高0.3967
- 今 开0.389
- 成交量 187.67万股
- 最 低 0.354
- 昨 收 0.3764
- 总市值 1894.37万
- 52周最高 15.80
- 市盈率 静 --
- 换手率 3.79%
- 52周最低 0.2012
- 委 比 -95.68%
- 总股本 4952.60万
- 历史最高 15.80
- 量 比 0.52
- 振 幅 11.34%
- 历史最低 0.2012
- 每 手 1
- 风险率 5.04%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aspire Biopharma Faces Nasdaq Delisting Notice
An update from Aspire Biopharma Holdings ( ($ASBP) ) is now available. Aspire B...
10-18 05:51
Nasdaq Surges 100 Points; AngioDynamics Posts Upbeat Q1 Results
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more ...
10-02 21:44
Aspire Biopharma Holdings shares are trading higher after the company announced a milestone roadmap targeting H2 2025 FDA Submission for Sublingual Asprin and 2026 milestones for Needle-Free Semaglutide and more-rapid ED medication.
Aspire Biopharma Holdings shares are trading higher after the company announced...
10-02 00:40
Aspire Biopharma Provides Pipeline Schedule
Anticipated Upcoming MilestonesSublingual High-dose Aspirin (Lead Program)H2 2025: Request meeting with FDA to discuss 505(b)(2) pathway.H2 2025: Target submission of New Drug Application (NDA).Sublingual ED medicationH1
10-01 20:39
Aspire Biopharma Expands BUZZ BOMB Pre-Workout Production With New SupraNaturals Manufacturing Agreement To Meet Growing Market Demand
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™
09-16 20:37
Aspire Biopharma Announces Final Results From Crossover Bioavailability Trial To Assess Safety, Tolerability, PK And PD Of Aspire's Investigational New Sublingual Aspirin Product Compared To Chewed Uncoated Aspirin Tablets In Healthy Adults
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping
09-03 20:32
Aspire Biopharma Secures $9.7M Through Securities Agreement
Aspire Biopharma Holdings ( ($ASBP) ) just unveiled an update. On August 19, 20...
08-23 05:53
Aspire Shares Are Trading Higher Monday: What's Going On?
Aspire shares are trading higher Monday after the company announced top-line data from its crossover bioavailability trial.
08-19 03:18
Aspire Biopharma Hldgs Q2 EPS $(0.04)
Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share.
08-14 05:50
Aspire Biopharma Launches BUZZ BOMB Pre-Workout With Innovative Sublingual Delivery
BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB™ sample
08-13 21:13
